On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Research Institute Hospital 12 de Octubre

InstitutionResearch output, impact & collaborations

Research Institute Hospital 12 de Octubre is a institution indexed in ScholarIQ from OpenAlex.

What is known about Research Institute Hospital 12 de Octubre?

ScholarIQrecord summary

Research Institute Hospital 12 de Octubre is a research organisation in Madrid, ES. OpenAlex records 15,605 works and 961,449 citations for it. 4,842 researchers list it as their most recent affiliation.

How many works does Research Institute Hospital 12 de Octubre have?

ScholarIQindexed works

Research Institute Hospital 12 de Octubre has 15,605 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Research Institute Hospital 12 de Octubre have?

ScholarIQcitation count

Research Institute Hospital 12 de Octubre has 961,449 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Research Institute Hospital 12 de Octubre?

ScholarIQresearcher count

Research Institute Hospital 12 de Octubre has 4,842 researchers in the ScholarIQ index.

What is the average h-index at Research Institute Hospital 12 de Octubre?

ScholarIQavg h-index

Research Institute Hospital 12 de Octubre has an average h-index of 58.9 in OpenAlex.

What is the ROR of Research Institute Hospital 12 de Octubre?

ScholarIQror

The ROR for Research Institute Hospital 12 de Octubre is on the source record.

What is the OpenAlex record for Research Institute Hospital 12 de Octubre?

ScholarIQopenalex

The OpenAlex for Research Institute Hospital 12 de Octubre is on the source record.

Who are the most-cited researchers behind Research Institute Hospital 12 de Octubre?

ScholarIQtop researchers by citations
1
Francisco Sánchez‐Madrid · Cell Adhesion Molecules Research
715 works57,957 citations
2
María Vallet‐Regí · Bone Tissue Engineering Materials
839 works56,054 citations
3
Juan José Lahuerta · Multiple Myeloma Research and Treatments
599 works31,106 citations
4
Eva Ciruelos · Advanced Breast Cancer Therapies
695 works19,915 citations
5
Fernando Caravaca‐Fontán · Renal Diseases and Glomerulopathies
180 works2,834 citations

What are the most-cited papers on Research Institute Hospital 12 de Octubre?

ScholarIQmost cited works
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Luca Gianni, W. Eiermann, Semiglazov Vf, Alexey Manikhas, Aňa Lluch, S. Tjulandin, Milvia Zambetti, Federico Vázquez, Mikhail Byakhow, Mikhail Lichinitser, Miguel Ángel Climent, Eva Ciruelos, B. Ojeda, Mauro Mansutti, А. А. Божок, Roberta Baronio, A. Feyereislova, Claire Barton, Pinuccia Valagussa, José Baselga
The Lancet. 20101,270 Citations
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Sandra M. Swain, David Miles, Sung‐Bae Kim, Young‐Hyuck Im, Seock‐Ah Im, Semiglazov Vf, Eva Ciruelos, Andreas Schneeweiß, Sherene Loi, Estefanía Monturus, Emma Clark, Adam Knott, Eleonora Restuccia, Mark Benyunes, Javier Cortés, Richy Agajanian, Rizvana Ahmad, Bahriye Aktas, Victor Hugo Medeiros Alencar, Dino Amadori, Jurandyr Moreira de Andrade, Fábio Franke, Catia Angiolini, Kenjiro Aogi, Jess F. Armor, Wichit Arpornwirat, L. Assersohn, William Audeh, Walter E. Aulitzky, Sérgio Jobim Azevedo, Maria Alejandra Bartoli, Norberto Batista López, María Inés Bianconi, Laura Biganzoli, Ruemu Birhiray, Marianna Bitiņa, Ron Blachy, Kimberly Blackwell, Rita A. Blanchard, Paulette Blanchet, Ion Boiangiu, B. Bower, Christine Brezden‐Masley, Adam Brufsky, Leanne S. Budde, Priscilla B. Caguioa, Lourdes Calvo, Mario Campone, Robert R. Carroll, Hugo R. Castro, Valorie F. Chan, Veena Charu, Saverio Cinieri, Michael Clemens, Emilio Alba Conejo, Eduardo Côrtes, Bruno Coudert, Eduardo Cronemberger, Daniel de Iracema Gomes Cubero, Shaker R. Dakhil, Brooke Daniel, Neville Davidson, Maria de Fátima Dias Gauí, Susana de la Cruz, María del Pilar, G. Delgado, John Ellerton, César Estuardo, Louis Fehrenbacher, Jean-­Marc Ferrero, Patrick J. Flynn, Małgorzata Foszczyńska‐Kłoda, Sandra Franco, Hirofumi Fujii, Chris Gallagher, Teresa Gamucci, N Giacomi, Miguel Gil Gil, Antonio González-Martı́n, Vera Gorbunova, E. Gotovkin, Nathan Green, Elza Grincuka, Eva‐Maria Grischke, Vincent Hansen, Jeffrey B. Hargis, Maik Hauschild, Roberto Hegg, Carolyn B. Hendricks, Róbert Hermann, Paulo M. Hoff, Jun Horiguchi, Javier Hornedo Muguiro, Stefano Iacobelli, Kenichi Inoue, Gustavo Ismael, Yoshinori Itoh, Dr Hiroji Iwata, D Jendiroba, Rosa Jochim
The Lancet Oncology. 2020917 Citations
The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from <scp>ASSURE</scp>‐<scp>CSU</scp>
Marcus Maurer, Mohamed Abuzakouk, F. Bérard, Giorgio Walter Canonica, Hanneke Oude Elberink, Ana M. Giménez‐Arnau, Clive Grattan, Kelly Hollis, André C. Knulst, J.‐P. Lacour, Charles Lynde, Alexander Marsland, Doreen McBride, Alla Nakonechna, F.J. Ortiz de Frutos, Christina Proctor, Gordon Sussman, Carolyn Sweeney, Hao Tian, Karsten Weller, Daniel Wolin, M.M. Balp
Allergy. 2017354 CitationsOPEN ACCESS
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
María‐Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold, Albert Oriol, David Simpson, Anupkumar George, Hartmut Goldschmidt, Alessandra Larocca, Asher Chanan‐Khan, Daniel W. Sherbenou, Irit Avivi, Noam Benyamini, Shinsuke Iida, Morio Matsumoto, Kenshi Suzuki, Vincent Ribrag, Saad Z. Usmani, Sundar Jagannath, Enrique M. Ocio, Paula Rodríguez‐Otero, Jesús F. San Miguel, Uma Kher, Mohammed Z.H. Farooqui, Jason J. Z. Liao, Patricia Marinello, Sagar Lonial, Andrew J. Nicol, George Grigoriadis, John Catalano, Richard LeBlanc, Mohamed Elemary, Nizar J. Bahlis, Thierry Façon, Lionel Karlin, Vincent Ribrag, Michel Attal, Hartmut Goldschmidt, Monika Engelhardt, Katja Weisel, Andréas Mackensen, Arnon Nagler, Dina Ben Yehuda, Irit Avivi, Noam Benyamini, Hila Magen‐Nativ, Antonio Palumbo, Michèle Cavo, Kensei Tobinai, Shinsuke Iida, Takaai Chou, Kenshi Suzuki, Hiroshi Kosugi, Masafumi Taniwaki, Kazutaka Sunami, Morio Matsumoto, Kiyoshi Ando, Peter Ganly, Hilary Blacklock, David Simpson, Anupkumar George, Fredrik Schjesvold, Bjørn Tore Gjertsen, Juan José Lahuerta, Joan Bladé, Albert Oriol Rocafiguera, María‐Victoria Mateos, Paula Rodríguez‐Otero, Sarah Larson, Djordje Atanackovic, Srinivas Devarakonda, Jacob D. Bitran, Jeffrey A. Zonder, Neil Morganstein, Mohammad Hay, Asher Chanan‐Khan, Gene Saylors, Ebenezer A. Kio, Ira Oliff, Dean Kirkel, Mikhail Shtivelband, Carrie Yuen, Andrew J. Yee, Jatin J. Shah, Myo Htut, Shahzad Raza, Saurabh Chhabra, Patrick J. Stiff, Parameswaran Hari, Bruce Bank, Ehsan Malek, Cristina Gasparetto, Ycaoub Faroun, Daniel W. Sherbenou, William Kreisle, Seema Singhal, Jacalyn Rosenblatt, Saad Z. Usmani, Wes Lee, Hana Safah, Jose Lutzky
The Lancet Haematology. 2019256 CitationsOPEN ACCESS
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Gema Fernández‐Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt, Joana Justino, Ángel Sevillano, Fernando Caravaca‐Fontán, Ana Ávila, Cristina Rabasco, Virginia Cabello, Alfonso Varela, Montserrat Díez, Guillermo Martín-Reyes, Marian Goicoechea Diezhandino, Luís F. Quintana, Irene Agraz, Juan Ramón Gomez-Martino, Mercedes Cao, Antolina Rodríguez-Moreno, Begoña Rivas, C. Galéano, J. Vilar Bonet, Ana Romera, Amir Shabaka, Emmanuelle Plaisier, Mario Espinosa, Jesús Egido, Alfonso Segarra, Gérard Lambeau, Pierre Ronco, Jack F.M. Wetzels, Manuel Praga, Manuel Praga, Ángel Sevillano, Fernando Caravaca‐Fontán, Hernando Trujillo, Eduardo Gutiérrez, Gema Fernández Juárez, Amir Shabaka, Jorge Rojas-Rivera, Jesús Egido, Alberto Ortíz, Marián Goicoechea, Úrsula Verdalles, Alfons Segarra, Irene Agraz, Guillermo Martín-Reyes, Lara Perea, Ildefonso Valera, Mónica Martín, Virginia Cabello, Miguel Ángel Pérez Valdivia, Luís F. Quintana, Miquel Blasco, Mercedes Cao, Andrés López Muñíz, Ana Ávila, T Małek, Mario Espinosa, Cristina Rabasco, Montserrat Díaz, Iara daSilva, Jordi Bonet, Maruja Navarro, Juan Ramón Gomez-Martino, Begoña Rivas, Antolina Rodríguez-Moreno, C. Galéano, Ana Romera, Ana Huerta, E. Rodriguez-Paternina, Ana Vigil, Roberto Alcázar, Vicente Paraíso, V. Barrio, Jack F.M. Wetzels, Anne-Els van de Logt, Julia M. Hofstra
Kidney International. 2020241 CitationsOPEN ACCESS

How much of the research on Research Institute Hospital 12 de Octubre is open access?

ScholarIQopen access share
75%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
42%
Bronze
17%
Closed
25%

Related on ScholarIQ

470M+ articles · 14-day free trial